SK281140B6 - (2r,3s)-beta-phenylisoserine and its salts and their preparation and use - Google Patents
(2r,3s)-beta-phenylisoserine and its salts and their preparation and use Download PDFInfo
- Publication number
- SK281140B6 SK281140B6 SK746-93A SK74693A SK281140B6 SK 281140 B6 SK281140 B6 SK 281140B6 SK 74693 A SK74693 A SK 74693A SK 281140 B6 SK281140 B6 SK 281140B6
- Authority
- SK
- Slovakia
- Prior art keywords
- beta
- liters
- toluene
- ammonia
- phenylisoserine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Oblasť technikyTechnical field
Vynález sa týka (2R,3S)-beta-fenylizoserínu vzorca (I)The invention relates to (2R, 3S) -beta-phenylisoserine of formula (I)
jeho solí s alkalickými kovmi, s kovmi alkalických zemín a s dusíkatými zásadami, spôsobu jeho prípravy a jeho použitia na prípravu terapeutických účinných látok.its alkali metal, alkaline earth metal and nitrogenous base salts, process for its preparation and its use for the preparation of therapeutic active substances.
Doterajší stav technikyBACKGROUND OF THE INVENTION
Zatiaľ čo izoméry (2R,3R), (2S,3S) a (2S,3R) beta-fenylizoserínu sú z vedeckej literatúry známe, napríklad z článkov E. Kamandiho a kol. v Árch. Pharmaz., 307, 871 až 878(1974), E. Kamandiho a kol. v Árch. Pharmaz., 308, 135 - 141(1975) alebo K. Haradaa a Y. Nakajimaa v Bull. Chem. Soc. Japan, 47, 2911 - 2912 (1974), nebol (2R,3S)-beta-fenylizoserín až dosiaľ opísaný inak ako vo forme esteru /H. Hônig a kol., Tetrahedron, 46 (11) 3841 - 3850 (1990)/.While the (2R, 3R), (2S, 3S) and (2S, 3R) beta-phenylisoserine isomers are known from the scientific literature, for example, the articles of E. Kamandi et al. in Árch. Pharmaz., 307, 871-878 (1974); E. Kamandi et al. in Árch. Pharmaz., 308, 135-141 (1975) or K. Harada and Y. Nakajima in Bull. Chem. Soc. Japan, 47, 2911-2 2912 (1974), (2R, 3S) -beta-phenylisoserine has not been previously described otherwise than in the form of the ester / H. Hönig et al., Tetrahedron, 46 (11) 3841-3850 (1990)].
Podstata vynálezuSUMMARY OF THE INVENTION
Podľa vynálezu sa môže (2R,3S)-beta-fenylizoserín, prípadne vo forme soli, získať pôsobením amoniaku na kyselinu (2R,3R)-beta-fenylglycidovú, výhodne vo forme soli s alkalickým kovom alebo kovom alkalických zemín (sodná, draselná alebo vápenatá soľ), amónnych solí alebo solí s dusíkatou zásadou (alfa-metyl-benzylamín, pyridín).According to the invention, (2R, 3S) -beta-phenylisoserine, optionally in the form of a salt, can be obtained by treating ammonia with (2R, 3R) -beta-phenylglycidic acid, preferably in the form of an alkali metal or alkaline earth metal salt (sodium, potassium or calcium salt), ammonium or nitrogen base salts (alpha-methylbenzylamine, pyridine).
Obvykle sa táto reakcia uskutočňuje vo vode, prípadne v zmesi s organickým rozpúšťadlom, akým je metanol. Výhodne sa uvedená reakcia uskutočňuje vo vode.Typically, this reaction is carried out in water, optionally in admixture with an organic solvent such as methanol. Preferably, said reaction is carried out in water.
Pri spôsobe podľa vynálezu je nevyhnutné použiť prebytok amoniaku vzhľadom na kyselinu (2R,3R)-beta-fenylglycidovú. Obvykle sa použije 10 až 100 molov amoniaku, výhodne 50 až 80 molov amoniaku na jeden mól kyseliny (2R,3R)-beta-fenylglycidovej.In the process according to the invention it is necessary to use an excess of ammonia relative to (2R, 3R) -beta-phenylglycidic acid. Usually 10 to 100 moles of ammonia, preferably 50 to 80 moles of ammonia, are used per mole of (2R, 3R) -beta-phenylglycidic acid.
Amoniak sa výhodne použije vo forme koncentrovaného vodného roztoku, akým je roztok, ktorého koncentrácia sa pri teplote blízkej 25 °C pohybuje v rozmedzí 20 až 32 % hmotnosti.The ammonia is preferably used in the form of a concentrated aqueous solution, such as a solution having a concentration in the range of 20 to 32% by weight at a temperature in the region of 25 ° C.
Spôsob podľa vynálezu sa uskutočňuje pri teplote 0 až 100 °C, výhodne pri teplote 40 až 60 °C. Obvykle sa pracuje za atmosférického tlaku alebo tiež pri autogénnom tlaku, ktorý sa pri teplote 60 °C rovná asi 0,25 MPa.The process according to the invention is carried out at a temperature of 0 to 100 ° C, preferably at a temperature of 40 to 60 ° C. Usually, the process is carried out at atmospheric pressure or else at an autogenous pressure, which at 60 [deg.] C. equals about 5 bar.
Na urýchlenie reakcie je obzvlášť výhodné pracovať v prítomnosti amónnej soli, akou je chlorid amónny alebo hydrogénuhličitan amónny. Výhodné je použiť hydrogenuhličitan amónny, ktorý umožňuje zvýšiť reakčnú rýchlosť pri zachovaní selektivity reakcie. Obvykle sa použije stechiometrické množstvo uvedenej amónnej soli vzhľadom na použité množstvo kyseliny beta-fenylglycidovej.To accelerate the reaction, it is particularly advantageous to work in the presence of an ammonium salt such as ammonium chloride or ammonium bicarbonate. It is preferred to use ammonium bicarbonate which allows to increase the reaction rate while maintaining the selectivity of the reaction. Usually, a stoichiometric amount of said ammonium salt relative to the amount of beta-phenylglycidic acid used is used.
Spôsob podľa vynálezu sa obvykle uskutočňuje použitím soli kyseliny (2R,3R)-beta-fenylglycidovej s alfa-metylbenzylamínom.The process according to the invention is usually carried out using a salt of (2R, 3R) -beta-phenylglycidic acid with alpha-methylbenzylamine.
Je však možné takisto použiť soľ alkalického kovu (sodná soľ, draselná soľ), ktorá sa získa pôsobením zásady (hydroxid sodný, hydroxid draselný) v stechiometrickom množstve na soľ kyseliny (2R,3R)-beta-fenylglycidovej s alfa-metylbenzylamínom, alebo amónnu soľ, ktorá sa získa pôsobením prebytku amoniaku na soľ kyseliny (2R,3R)-beta-fenylglycidovej s alfa-metylbenzylamínom. V tomto poslednom uvedenom prípade jc možné priaznivo ovplyvniť priebeh reakcie kontinuálnou alebo semikontinuálnou extrakciou alfa-mctylbcnzylamínu vhodným organickým rozpúšťadlom, akým je toluén.However, it is also possible to use an alkali metal salt (sodium salt, potassium salt), which is obtained by treating the (2R, 3R) -beta-phenylglycidic acid salt with alpha-methylbenzylamine or ammonium by stoichiometric treatment with a base (sodium hydroxide, potassium hydroxide). a salt which is obtained by treating an excess of ammonia with a salt of (2R, 3R) -beta-phenylglycidic acid with alpha-methylbenzylamine. In the latter case, the course of the reaction can be favorably influenced by continuous or semi-continuous extraction of alpha-methylbenzylamine with a suitable organic solvent such as toluene.
Obzvlášť zaujímavé je použiť amónnu soľ kyseliny (2R,3R)-beta-fenylglycidovej, ktorá umožňuje otvorenie kruhu amoniakom, ktoré je regioselektívne a stereoselektívne.Of particular interest is the use of the ammonium salt of (2R, 3R) -beta-phenylglycidic acid, which allows ring opening by ammonia, which is regioselective and stereoselective.
Bez ohľadu na to, akým spôsobom sa pôsobí amoniakom na kyselinu (2R,3R)-beta-fenylglycidovú, sa môže (2R,3S)-beta- fenylizoserín izolovať jednou z nasledujúcich metód:Regardless of how (2R, 3R) -beta-phenylglycidic acid is treated with ammonia, (2R, 3S) -beta-phenylisoserine can be isolated by one of the following methods:
1. Prebytok amoniaku sa môže odstrániť za zníženého tlaku tak, aby sa získal vodný roztok amónnej soli kyseliny (2R,3S)-beta-fenylglycidovej. Po pridaní silnej minerálnej kyseliny sa vyzráža (2R,3S)-beta-fenylizoserín, ktorý sa oddelí filtráciou, alebo1. Excess ammonia can be removed under reduced pressure to obtain an aqueous solution of (2R, 3S) -beta-phenylglycidic acid ammonium salt. Upon addition of a strong mineral acid, (2R, 3S) -beta-phenylisoserine precipitates which is separated by filtration, or
2. pred odstránením, v priebehu odstránenia alebo po odstránení amoniaku za zníženého tlaku je možné pridať zásadu alkalického kovu (hydroxid sodný alebo hydroxid draselný) alebo kovu alkalických zemín (oxid vápenatý, hydroxid vápenatý); vytvorená soľ sa vyzráža po prípadnom pridaní organického rozpúšťadla, akým je acetón. Takto získaná soľ alkalického kovu alebo kovu alkalických zemín sa oddelí filtráciou. S cieľom ľahšie vysoliť soľ, obzvlášť sodnú soľ (2R,3S)-beta-fenylizoserínu, a zlepšiť výťažo, sa môže výhodne nasýtiť voda prítomná v reakčnej zmesi pridaním chloridu sodného.2. an alkali metal (sodium hydroxide or potassium hydroxide) or an alkaline earth metal (calcium oxide, calcium hydroxide) may be added before, during or after the removal of ammonia under reduced pressure; the salt formed precipitates upon optional addition of an organic solvent such as acetone. The alkali metal or alkaline earth metal salt thus obtained is separated by filtration. In order to facilitate the salting out of the salt, especially the sodium salt of (2R, 3S) -beta-phenylisoserine, and to improve the yield, it is advantageous to saturate the water present in the reaction mixture by adding sodium chloride.
Uvedená kyselina (2R,3R)-beta-fenylglycidová sa môže pripraviť za podmienok opísaných J. N. Denisom a kol. v J. Org. Chem., 51, 46 - 50 (1986).Said (2R, 3R) -beta-phenylglycidic acid may be prepared under the conditions described by J. N. Denis et al. in J. Org. Chem., 51, 46-50 (1986).
(2R,3S)-beta-Fenylizoserín získaný spôsobom podľa vynálezu je obzvlášť vhodný na syntézu terapeuticky účinných zlúčenín, akými sú deriváty taxánu všeobecného vzorca (II)The (2R, 3S) -beta-phenylisoserine obtained by the process of the invention is particularly suitable for the synthesis of therapeutically active compounds such as the taxane derivatives of formula (II)
v ktorom R znamená atóm vodíka alebo acetylovú skupinu a R1 znamená fenylovú skupinu alebo íerc-butoxyskupinu.wherein R is hydrogen or acetyl and R 1 is phenyl or tert-butoxy.
Pôsobením benzoylačného činidla (benzoylchlorid) alebo ŕerc-butoxykarbonylačného činidla (terc-butyldikarbonát) a potom činidla na ochranu funkčnej hydroxylovej skupiny sa z beta-fenylizoserínu získa zlúčenina všeobecného vzorca (III) r’conhBy treatment with a benzoylating agent (benzoyl chloride) or a tert-butoxycarbonylating agent (tert-butyl dicarbonate) and then a hydroxyl-protecting agent, a compound of formula (III) is obtained from beta-phenylisoserine r'conh
v ktorom R1 znamená fenylovú skupinu alebo íerc-butoxyskupinu a Z1 znamená ochrannú skupinu funkčnej hydroxylovej skupiny (1-etoxyetylová skupina).wherein R 1 represents a phenyl or tert-butoxy group and Z 1 represents a protecting group of a functional hydroxyl group (1-ethoxyethyl).
Kondenzáciou kyseliny všeobecného vzorca (III) s baccatinom III alebo 10-deacetylbaccatinom III, ktorého hydroxyskupiny v polohe 7 a prípadne v polohe 10 sú chránené ochrannými skupinami (silylované skupiny, 2,2,2,-trichlóretoxykarbonylová skupina), a následným nahradením uvedených ochranných skupín atómami vodíka sa získa produkt všeobecného vzorca (II).Condensation of an acid of formula (III) with baccatin III or 10-deacetylbaccatin III, the hydroxyl groups of which at the 7-position and optionally at the 10-position are protected (silylated, 2,2,2, -trichloroethoxycarbonyl), and subsequently replaced groups of hydrogen atoms to give the product of formula (II).
Uvedená kondenzácia kyseliny všeobecného vzorca (III) s baccatinom III alebo s 10-deacetylbaccatinom III, chráneným uvedeným spôsobom, ako aj nahradenie ochranných skupín atómami vodíka sa môže vykonať za podmienok opísaných v európskych patentoch EP-0 336 840 aleboSaid condensation of an acid of formula (III) with baccatin III or with 10-deacetylbaccatin III protected as described above, as well as the replacement of the protecting groups with hydrogen atoms can be carried out under the conditions described in European patents EP-0 336 840 or
EP-0 336 841.EP-0 336 841.
V nasledujúcej časti opisu bude vynález bližšie objasnený pomocou príkladov jeho konkrétneho uskutočnenia, ktoré však majú iba ilustračný charakter a nijako neobmedzujú rozsah vynálezu, ktorý je jednoznačne vymedzený formuláciou patentových nárokov.In the following, the invention will be further elucidated by means of examples of specific embodiments thereof, which, however, are provided by way of illustration only and are not intended to limit the scope of the invention as defined by the claims.
% chloridu sodného a asi 5,300 kg sodnej soli čistého (2R,3S)-beta-fenylizoserínu.% sodium chloride and about 5,300 kg of pure (2R, 3S) -beta-phenylisoserine sodium.
Výťažok sa rovná 72 %.Yield 72%.
Takto získaná zlúčenina sa môže samotná použiť pri reakčných stupňoch nasledujúcich syntéz.The compound thus obtained can itself be used in the reaction steps of the following syntheses.
Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9100491A FR2671799B1 (en) | 1991-01-17 | 1991-01-17 | B-PHENYLISOSERINE- (2R, 3S), ITS SALTS, ITS PREPARATION AND ITS USE. |
PCT/FR1992/000032 WO1992012958A1 (en) | 1991-01-17 | 1992-01-16 | β-PHENYLISOSERINE-(2R,3S), SALTS, PREPARATION AND USE THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
SK74693A3 SK74693A3 (en) | 1994-03-09 |
SK281140B6 true SK281140B6 (en) | 2000-12-11 |
Family
ID=9408773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK746-93A SK281140B6 (en) | 1991-01-17 | 1992-01-16 | (2r,3s)-beta-phenylisoserine and its salts and their preparation and use |
Country Status (25)
Country | Link |
---|---|
EP (2) | EP0495718A1 (en) |
JP (1) | JP3233632B2 (en) |
KR (1) | KR100235372B1 (en) |
AT (1) | ATE157081T1 (en) |
AU (1) | AU651669B2 (en) |
CA (1) | CA2099783C (en) |
CZ (1) | CZ281266B6 (en) |
DE (1) | DE69221733T3 (en) |
DK (1) | DK0603176T4 (en) |
ES (1) | ES2104895T5 (en) |
FI (1) | FI113641B (en) |
FR (1) | FR2671799B1 (en) |
GR (1) | GR3024533T3 (en) |
HU (1) | HU213616B (en) |
IE (1) | IE920127A1 (en) |
MX (1) | MX9200181A (en) |
NO (1) | NO303539B1 (en) |
NZ (1) | NZ241312A (en) |
PL (1) | PL167676B1 (en) |
RU (1) | RU2090551C1 (en) |
SK (1) | SK281140B6 (en) |
TW (1) | TW221413B (en) |
WO (1) | WO1992012958A1 (en) |
YU (1) | YU48153B (en) |
ZA (1) | ZA92317B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646176A (en) | 1992-12-24 | 1997-07-08 | Bristol-Myers Squibb Company | Phosphonooxymethyl ethers of taxane derivatives |
TW467896B (en) | 1993-03-19 | 2001-12-11 | Bristol Myers Squibb Co | Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes |
PL368945A1 (en) | 2001-11-30 | 2005-04-04 | Bristol-Myers Squibb Company | Paclitaxel solvates |
JP7028194B2 (en) | 2017-02-10 | 2022-03-02 | 日本電気株式会社 | Knowledge generator for inference, knowledge generation method for inference, and program |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2629819B1 (en) † | 1988-04-06 | 1990-11-16 | Rhone Poulenc Sante | PROCESS FOR THE PREPARATION OF BACCATIN III AND DESACETYL-10 BACCATIN III DERIVATIVES |
FR2629818B1 (en) † | 1988-04-06 | 1990-11-16 | Centre Nat Rech Scient | PROCESS FOR THE PREPARATION OF TAXOL |
CA2023645C (en) † | 1989-08-23 | 2002-03-26 | Jean-Noel Denis | Process for the enantioselective preparation of phenylisoserin derivatives |
-
1991
- 1991-01-17 FR FR9100491A patent/FR2671799B1/en not_active Expired - Lifetime
-
1992
- 1992-01-15 NZ NZ241312A patent/NZ241312A/en not_active IP Right Cessation
- 1992-01-16 TW TW081100266A patent/TW221413B/zh not_active IP Right Cessation
- 1992-01-16 JP JP50400792A patent/JP3233632B2/en not_active Expired - Fee Related
- 1992-01-16 IE IE012792A patent/IE920127A1/en not_active IP Right Cessation
- 1992-01-16 EP EP92400112A patent/EP0495718A1/en active Pending
- 1992-01-16 SK SK746-93A patent/SK281140B6/en not_active IP Right Cessation
- 1992-01-16 RU RU9293051781A patent/RU2090551C1/en active
- 1992-01-16 PL PL92299833A patent/PL167676B1/en unknown
- 1992-01-16 MX MX9200181A patent/MX9200181A/en active IP Right Grant
- 1992-01-16 WO PCT/FR1992/000032 patent/WO1992012958A1/en active IP Right Grant
- 1992-01-16 CZ CS931390A patent/CZ281266B6/en not_active IP Right Cessation
- 1992-01-16 DE DE69221733T patent/DE69221733T3/en not_active Expired - Lifetime
- 1992-01-16 KR KR1019930702148A patent/KR100235372B1/en not_active IP Right Cessation
- 1992-01-16 HU HU9302064A patent/HU213616B/en unknown
- 1992-01-16 EP EP92904034A patent/EP0603176B2/en not_active Expired - Lifetime
- 1992-01-16 ZA ZA92317A patent/ZA92317B/en unknown
- 1992-01-16 CA CA002099783A patent/CA2099783C/en not_active Expired - Lifetime
- 1992-01-16 AU AU12237/92A patent/AU651669B2/en not_active Expired
- 1992-01-16 AT AT92904034T patent/ATE157081T1/en not_active IP Right Cessation
- 1992-01-16 ES ES92904034T patent/ES2104895T5/en not_active Expired - Lifetime
- 1992-01-16 DK DK92904034T patent/DK0603176T4/en active
- 1992-01-17 YU YU5492A patent/YU48153B/en unknown
-
1993
- 1993-07-06 NO NO932458A patent/NO303539B1/en not_active IP Right Cessation
- 1993-07-16 FI FI933249A patent/FI113641B/en active
-
1997
- 1997-08-26 GR GR960402650T patent/GR3024533T3/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070185336A1 (en) | Process for preparing n-protected 4-ketoproline derivatives | |
IE922234A1 (en) | Process for the preparation of derivatives of baccatin III and of 10-deacetylbaccatin III | |
FR2697522A1 (en) | Process for the preparation of taxane derivatives. | |
CA2205745C (en) | Method for the preparation of baccatin iii and derivatives thereof from 10-deacetylbaccatin iii | |
HUT68255A (en) | Process for the preparation of beta-phenylisoserine derivatives and use thereof | |
HU209615B (en) | Process for preparing derivatives of beta-phenylisoserine | |
SK281140B6 (en) | (2r,3s)-beta-phenylisoserine and its salts and their preparation and use | |
EP0210896B1 (en) | Optically pure derivates of 4-amino-3-hydroxycarboxylic acids and process for stereospecific synthesis | |
US5684168A (en) | β-phenylisoserine-(2R,3S), salts, preparation and use thereof | |
JP2021504324A (en) | Process for preparing acylated amphetamine derivatives | |
WO2000044706A1 (en) | PROCESS FOR THE PREPARATION OF α-AMINOKETONES | |
JP2002505317A (en) | Synthesis of chiral β-amino acids | |
FR2669031A1 (en) | PROCESS FOR THE PREPARATION OF TETRAHYDROPYRANE DERIVATIVES. | |
US6320072B1 (en) | Method for isolation of n-protected s-phenylcysteine | |
JPH05255243A (en) | Aziridine-2-carboxylic acid derivative and method for producing the same | |
JPH08208530A (en) | Method for removing phthaloyl group of phthalimide compound | |
FR2670490A1 (en) | Process for the preparation of "syn" propanamide derivatives | |
CZ20003887A3 (en) | Isolation process of N-protected-S-phenylcysteine | |
JPH10287661A (en) | Production of furanone ether derivative | |
JPS61129177A (en) | Method for producing epoxysuccinic acid monoester derivatives | |
HU217978B (en) | Process for producing taxane derivatives with using (2r,3s)-betha-phenyl-isoserine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Patent expired |
Expiry date: 20120116 |